Efficacy and Clinical Outcomes of Remdesivir Plus Intravenous Cefepime Compared to Remdesivir Plus Intravenous Levofloxacin in Type 2 Diabetes Mellitus Iraqi Patients with COVID -19. Journal of Pharmaceutical Negative Results, [S. l.], v. 13, n. 2, p. 82–86, 2022. Disponível em: https://mail.pnrjournal.com/index.php/home/article/view/199.. Acesso em: 10 jun. 2026.